PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 45 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

18 March 2025

  1. (diff | hist) 13:40 Talk:Vial 611 +341 StopperingSteff (talk | contribs) /* Merge proposal: Multi-dose vial into this article */ reply
  2. (diff | hist) 13:25 Placebo-adjusted effect 3,671 ±0 GramsNotUnitsGil (talk | contribs) attribute the subgroup finding as exploratory [rollback]
  3. (diff | hist) 10:52 Talk:Vial 400 +379 MergeMorwenna (talk | contribs) /* Merge proposal: Multi-dose vial into this article */ new section
  4. (diff | hist) 05:36 Fmoc chemistry 4,412 +694 GradientGus (talk | contribs) expand §Why the scheme matters downstream [rollback]

17 March 2025

  1. (diff | hist) 23:58 Cold-chain freight 3,699 +474 TesamorelinTeg (talk | contribs) add the collapse-temperature point, sourced [rollback]
  2. (diff | hist) 22:14 Cagrilintide 3,187 ±0 MolarMassMaeve (talk | contribs) expand §Material sold under the name [rollback]
  3. (diff | hist) 18:49 Tianjin Finder Chemical 6,607 +144 UnderfillUna (talk | contribs) add the storage and handling guidance the organisation publishes [rollback]
  4. (diff | hist) 15:41 Cold chain 20,222 +1,422 ReceptorRhoda (talk | contribs) expand §Packaging and qualification [rollback]
  5. (diff | hist) 12:56 International nonproprietary name 3,145 ±0 TirzTaxonomist (talk | contribs) give the strength per pen as well as per millilitre [rollback]
  6. (diff | hist) m 12:37 Crude peptide 3,916 +265 ColdChainCleo (talk | contribs) expand §What is in it [rollback]
  7. (diff | hist) 09:44 TRIUMPH trial programme 4,014 +519 MoveRequestMio (talk | contribs) convert the endpoint list to a table for comparability [rollback]
  8. (diff | hist) 08:37 List of GLP-1 receptor agonists 3,023 ±0 StubTagTeodor (talk | contribs) correct a wikilink that pointed at the disambiguation page [rollback]
  9. (diff | hist) m b 07:56 Reference standard 4,120 ±0 CiteBot (talk | contribs) bot: sort category members [rollback]
  10. (diff | hist) 06:44 ChinaPeptides 7,281 +274 TallySheetTad (talk | contribs) expand §Regulatory position and legal status [rollback]
  11. (diff | hist) m b 06:10 Dose escalation schedule 3,650 +18 CiteBot (talk | contribs) bot: sort category members [rollback]
  12. (diff | hist) 05:33 Guangzhou JEEP Biotechnology 9,996 +342 EndotoxinEd (talk | contribs) expand §Product range [rollback]
  13. (diff | hist) 02:59 Patent expiry and biosimilars 3,173 ±0 API_Aurora (talk | contribs) add the good-manufacturing-practice framework by name [rollback]

16 March 2025

  1. (diff | hist) m b 22:34 Weight regain after discontinuation 4,031 ±0 ArchiveBot (talk | contribs) bot: expand PMID to full citation [rollback]
  2. (diff | hist) 18:18 Melanotan II 3,391 +33 SchematicScout (talk | contribs) the sequence in the infobox was missing the C-terminal amide; added [rollback]
  3. (diff | hist) m b 10:59 Sterile water for injection 3,619 ±0 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  4. (diff | hist) 09:15 Talk:Flourishglobal Peptide Biotech 822 +60 NotabilityNoa (talk | contribs) /* Notability: smaller report base */ reply
  5. (diff | hist) 08:22 Good manufacturing practice 3,548 ±0 MOTSc_Mira (talk | contribs) add the note that a certificate of analysis has no regulatory standing [rollback]
  6. (diff | hist) 02:35 Fasting insulin 2,962 ±0 B12_Bettina (talk | contribs) split the analytical performance from the clinical interpretation [rollback]
  7. (diff | hist) m 01:28 Retatrutide 5,700 ±0 SemaglutideSasha (talk | contribs) expand §Material sold as retatrutide [rollback]
  8. (diff | hist) 00:40 Batch number 3,708 ±0 ChainCustodyChad (talk | contribs) British spelling per PP:MOS [rollback]

15 March 2025

  1. (diff | hist) 20:54 Resin cleavage 3,277 ±0 ColdChainCleo (talk | contribs) ce per PP:MOS [rollback]
  2. (diff | hist) 16:50 Shanghai Sigma-Audley New Material Technology 7,517 +507 COA_Colwyn (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  3. (diff | hist) m 07:29 Peptide synthesis 4,113 ±0 RepackRadek (talk | contribs) state that overlay gas is used and name it [rollback]
  4. (diff | hist) 07:07 Amylin 4,252 ±0 Peptide_Pete (talk | contribs) add the molecular formula to the infobox [rollback]
  5. (diff | hist) 02:58 Aspiration risk under anaesthesia 3,880 +155 MTC_Marisol (talk | contribs) give the incidence with its denominator [rollback]
  6. (diff | hist) m 01:12 Insulin syringe 4,111 ±0 SharpsSukhi (talk | contribs) rm the titration schedule — that belongs on the compound article [rollback]
  7. (diff | hist) m 00:38 Medutest 3,795 ±0 ApoB_Aurelio (talk | contribs) fix hyphenation per PP:MOS [rollback]

14 March 2025

  1. (diff | hist) 22:39 Solid-phase peptide synthesis 5,076 +797 MissedDoseMik (talk | contribs) space between number and unit per PP:MOS [rollback]
  2. (diff | hist) m 20:07 Grey market 2,576 ±0 Ref_Desk_Ron (talk | contribs) expand §What the term does not mean [rollback]
  3. (diff | hist) m b 18:08 Shanghai Wibson Biotechnology 5,502 +192 CiteBot (talk | contribs) bot: sort category members [rollback]
  4. (diff | hist) m b 17:08 Bacteriostatic water 3,824 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  5. (diff | hist) 16:42 SELECT trial 4,206 ±0 Chromatokid (talk | contribs) state the non-inferiority margin, since the design was non-inferiority [rollback]
  6. (diff | hist) 15:53 Limit of detection 3,971 ±0 ITT_Imelda (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]
  7. (diff | hist) 14:58 Area percent purity 6,569 ±0 MassSpecMarv (talk | contribs) fix hyphenation per PP:MOS [rollback]
  8. (diff | hist) 14:47 Talk:Flourishglobal Peptide Biotech 611 +165 TallySheetTad (talk | contribs) /* Notability: smaller report base */ reply
  9. (diff | hist) 11:22 Talk:Flourishglobal Peptide Biotech 400 +427 NotabilityNoa (talk | contribs) /* Notability: smaller report base */ new section
  10. (diff | hist) 06:55 Reverse-phase HPLC 4,246 ±0 Chromatokid (talk | contribs) consistent en dashes in ranges [rollback]
  11. (diff | hist) 06:41 Custom peptide synthesis 3,777 +378 DiluentDiya (talk | contribs) close an unbalanced quotation mark [rollback]
  12. (diff | hist) 06:15 Chain of custody 4,085 +169 API_Aurora (talk | contribs) clarify that a certificate is a claim by its issuer [rollback]
  13. (diff | hist) 06:13 Beyond-use date 12,094 +1,001 RotationRosalind (talk | contribs) expand §Assignment in the absence of data [rollback]
  14. (diff | hist) 05:35 Arcuate nucleus 4,321 ±0 TesamorelinTeg (talk | contribs) clarify that the receptor is expressed outside the pancreas [rollback]
  15. (diff | hist) m 00:58 Flourishglobal Peptide Biotech 2,841 +38 PriorAuthPaz (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  16. (diff | hist) m 00:38 Oral semaglutide 3,519 ±0 CuriousCallum (talk | contribs) the lead claimed weekly dosing for a compound dosed daily; corrected [rollback]

13 March 2025

  1. (diff | hist) 23:24 Karl Fischer titration 7,045 +486 TFA_Counterion (talk | contribs) add the counterion determination method by name [rollback]
  2. (diff | hist) 20:53 Hunan Aslsen Technology 8,479 +764 SyringeSybille (talk | contribs) add the standing talk-page note link to the banner [rollback]
  3. (diff | hist) m 19:46 Mass spectrometry 5,223 +896 RepackRadek (talk | contribs) add the cross-link to the compendial chapter [rollback]
  4. (diff | hist) 12:28 MOTS-c 2,696 +33 TirzTaxonomist (talk | contribs) add the parent protein and the residue range the fragment spans [rollback]
  5. (diff | hist) m 03:14 Peptide harm reduction 3,320 +535 MTC_Marisol (talk | contribs) add the year-on-year change with both endpoints stated [rollback]

12 March 2025

  1. (diff | hist) m b 20:36 Chinese Peptide Company 9,974 +479 CiteBot (talk | contribs) bot: mark outbound storefront link nofollow [rollback]
  2. (diff | hist) 17:42 Contract development and manufacturing organisation 3,584 +122 ResolutionRoo (talk | contribs) ce, tighten prose [rollback]
  3. (diff | hist) 15:20 Vial filling and stoppering 3,756 +89 CouplingCillian (talk | contribs) ce, tighten prose [rollback]
  4. (diff | hist) m 14:39 Amylin receptor agonist 3,909 +287 PrepHPLC_Pia (talk | contribs) alphabetise the see-also list [rollback]
  5. (diff | hist) m b 12:43 Receptor bias 3,517 ±0 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  6. (diff | hist) 12:33 Bacterial endotoxin test 4,398 ±0 ResolutionRoo (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]
  7. (diff | hist) m 09:47 Third-party testing 5,770 ±0 AnalyticalAnnie (talk | contribs) give the fields a compendially-complete certificate would carry [rollback]
  8. (diff | hist) 08:35 Talk:Peptide supply chain 959 +116 ColdChainCleo (talk | contribs) /* Repackaging: how common is it really? */ reply
  9. (diff | hist) 07:46 Timeline of incretin therapeutics 3,151 ±0 TalkPageTaro (talk | contribs) fix the amino-acid substitution — position 8, not position 2 [rollback]
  10. (diff | hist) 02:07 Survodutide 4,470 +465 AmylinAmos (talk | contribs) expand §Design and rationale [rollback]

11 March 2025

  1. (diff | hist) 23:57 GL Biochem (Shanghai) 11,732 +943 COA_Colwyn (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]
  2. (diff | hist) 23:09 Qingdao Sigma Chemical 9,227 +392 UnitsUrsula (talk | contribs) expand §Distribution and dispatch [rollback]
  3. (diff | hist) m 20:11 Customs seizure 3,014 ±0 SortKeySascha (talk | contribs) state that research-use-only labelling is a commercial category, not an approval [rollback]
  4. (diff | hist) 16:57 Wuhan Wansheng Biotechnology 10,241 +479 ForgeryFinder (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  5. (diff | hist) m 15:19 Prior authorisation 2,250 ±0 TierTwoTansy (talk | contribs) space between number and unit per PP:MOS [rollback]
  6. (diff | hist) 14:58 USP General Chapter 71 3,092 +122 AnalyticalAnnie (talk | contribs) fix the anchor on an internal link [rollback]
  7. (diff | hist) m 14:32 Reconstitution calculator 5,276 ±0 LurkerLevi (talk | contribs) add the medical-disclaimer cross-link to the tool pages [rollback]
  8. (diff | hist) 13:52 Talk:Peptide supply chain 748 +237 CustomsClarke (talk | contribs) /* Repackaging: how common is it really? */ reply
  9. (diff | hist) 13:49 Vial 17,729 ±0 CounterfeitCato (talk | contribs) split §Cold chain from §Storage after receipt [rollback]
  10. (diff | hist) m b 11:10 Drug master file 3,180 +104 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  11. (diff | hist) 09:28 Talk:Peptide supply chain 537 +187 LotTraceLuka (talk | contribs) /* Repackaging: how common is it really? */ new section
  12. (diff | hist) 05:48 Multi-dose vial 7,432 +3,066 Chromatokid (talk | contribs) the example withdrew more than the syringe holds; corrected [rollback]
  13. (diff | hist) 05:15 Albumin binding half-life extension 4,872 ±0 Peptide_Pete (talk | contribs) state that the receptor is a class B G-protein-coupled receptor [rollback]
  14. (diff | hist) 04:00 Dual incretin agonist 4,734 ±0 BacWaterBarnaby (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]

10 March 2025

  1. (diff | hist) m 16:06 Peptide aggregation 4,041 +13 Chromatokid (talk | contribs) add the note on co-elution and what it hides [rollback]
  2. (diff | hist) m b 14:16 GLP-1 receptor 6,105 ±0 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  3. (diff | hist) m 12:33 SURMOUNT trial programme 3,559 ±0 SurpassSunniva (talk | contribs) add the PMID [rollback]
  4. (diff | hist) m b 06:12 Gastric emptying 4,636 ±0 CiteBot (talk | contribs) bot: expand PMID to full citation [rollback]
  5. (diff | hist) 00:34 STEP trial programme 4,357 ±0 DMF_Dermot (talk | contribs) add the run-in period, which changes how the baseline reads [rollback]

9 March 2025

  1. (diff | hist) 22:07 Purity claim inflation 3,723 +120 UnderfillUna (talk | contribs) add the note that self-submitted reports are a self-selected sample [rollback]
  2. (diff | hist) 17:45 Dulaglutide 4,161 +171 MolarMassMaeve (talk | contribs) convert the substitution list to a table so the analogues line up [rollback]
  3. (diff | hist) 16:15 Analytical method validation 4,442 +421 UnderfillUna (talk | contribs) add the cross-link to the compendial chapter [rollback]
  4. (diff | hist) m b 15:11 Baseline laboratory panel 3,039 +74 CategoryBot (talk | contribs) bot: add stub category [rollback]
  5. (diff | hist) 11:28 Trifluoroacetate counterion 3,489 ±0 TechnicianTeal (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  6. (diff | hist) m 08:51 Peptide content 6,547 +469 GradientGus (talk | contribs) add the sample preparation, since the result depends on it [rollback]
  7. (diff | hist) 07:45 Global access disparity 2,619 ±0 ForgeryFinder (talk | contribs) rm the projection; nothing cited supports it [rollback]
  8. (diff | hist) 07:09 Preparative HPLC purification 3,866 ±0 SupplyWatchSuri (talk | contribs) copyedit [rollback]
  9. (diff | hist) 04:39 Research use only 6,689 ±0 PharmDrafts (talk | contribs) attribute the enforcement statement to the published policy [rollback]

8 March 2025

  1. (diff | hist) m 18:13 Cost per milligram 2,123 ±0 HOMA_Hettie (talk | contribs) clarify that coverage varies by plan and give the source for the example [rollback]
  2. (diff | hist) m 16:49 WuXi TIDES 10,180 +498 SchematicScout (talk | contribs) add the reception tally with its period and count stated [rollback]
  3. (diff | hist) 13:44 Contraindications of incretin therapy 3,570 +162 INN_Ingrid (talk | contribs) expand §Scope of this article [rollback]
  4. (diff | hist) 12:33 Personal importation policy 3,034 +28 FiveOhThreeB (talk | contribs) state that a GMP claim is not a fact until assessed [rollback]
  5. (diff | hist) 11:54 Body composition assessment 4,060 ±0 DrTitration (talk | contribs) expand §Methods and their precision [rollback]
  6. (diff | hist) 09:30 Sarcopenia 3,319 +581 AnalyticalAnnie (talk | contribs) state the assay the reference interval was established on [rollback]
  7. (diff | hist) m 03:18 Insulin secretion 5,442 ±0 LyophilLena (talk | contribs) give the magnitude of the incretin effect as a percentage of the insulin response [rollback]
  8. (diff | hist) 03:05 Peptide stability table 3,914 +313 SchemaSorcha (talk | contribs) give the figures to a consistent number of significant figures [rollback]
  9. (diff | hist) 01:24 SURPASS trial programme 3,958 ±0 ChromCleanupCass (talk | contribs) serial comma per PP:MOS [rollback]